Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Canagliflozin: Impact on Health Status, Quality of Life, and Functional Status in Heart Failure

NCT04252287 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

NCT NCT04252287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04252287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Canagliflozin: Impact on Health Status, Quality of Life, and Functional Status in Heart Failure
Lead sponsor
Janssen Research & Development, LLC
Phase
Phase 3
Overall status
Completed
Start date
March 10, 2020
Completion date
November 9, 2021
Enrollment
476 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure